MPO and mixed phenotype acute leukemia: The new classification system proposes the diagnosis of mixed-phenotype acute leukemia (MPAL) and emphasizes the impact of CD19 for B-cell lineage, CD3/cCD3 for T-cell lineage, and cytoplasmatic myeloperoxidase (MPO) for myeloid lineage, respectively4,5.